Search Results 201-210 of 23016 for Phase

  1. A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression - Mayo Clinic

    A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression.

  2. EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures - Mayo Clinic

    This phase II multi-centered, randomized controlled trial of mechanical ventilation directed by esophageal pressure measurement will test the primary hypothesis ...

  3. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    TP-0903 is shown to block cancer cell epithelial-to-mesenchymal transitions. AXL was identified as a potential therapeutic target in chronic lymphocytic ...

  4. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

    Patients with previously untreated low tumor burden indolent Non-Hodgkin's Lymphoma (NHL) will receive either rituximab or GA101 weekly for 4 weeks followed by ...

  5. Delayed sleep phase - Doctors and departments - Mayo Clinic

    Publications. See a list of publications about delayed sleep phase by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

  6. A Phase 1/2 Trial of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 as Neoadjuvant Chemotherapy in Locally Advanced, Unresectable Pancreatic Cancer - Mayo Clinic

    A Phase 1/2 Trial of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 as Neoadjuvant Chemotherapy in Locally Advanced, Unresectable Pancreatic Cancer.

  7. Impact Of 1 Mg Osilodrostat Therapy On Mild Autonomous Cortisol Secretion (MACS) - Mayo Clinic

    Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases ...

  8. Phase IIa Study Evaluating AZD7798 in Crohn's Disease (AMALTHEA) - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of AZD7798 in participants with moderate to severe Crohn's disease. Participation eligibility.

  9. A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

    The purpose of this dose escalation study is to evaluate the safety profile of escalating doses and dose schedules of NXP900. Participation eligibility.

  10. The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis - Mayo Clinic

    Subjects will remain on-study until study completion, which will occur when all primary endpoint events (all-cause mortality or cardiac hospitalizations) have ...